Optimizing bevacizumab dosing in glioblastoma: less is more. [electronic resource]
Producer: 20180620Description: 99-105 p. digitalISSN:- 1573-7373
- Antineoplastic Agents, Immunological -- administration & dosage
- Bevacizumab -- administration & dosage
- Brain Neoplasms -- drug therapy
- Chemoradiotherapy
- Dose-Response Relationship, Drug
- Female
- Glioblastoma -- drug therapy
- Humans
- Incidence
- Male
- Middle Aged
- Neoplasm Grading
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.